Vimarsana
Biggest News Aggregation in the World

Psychometric Properties News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Psychometric Properties. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Psychometric Properties Today - Breaking & Trending Today

"Translation and validation of the Chinese version of Palliative Care S" by Junchen Guo, Yongyi Chen et al. - Vimarsana News

"Translation and validation of the Chinese version of Palliative Care S" by Junchen Guo, Yongyi Chen et al.

Objectives. Accurately assessing the self-efficacy levels of palliative care professionals’ is crucial, as low levels of self-efficacy may contribute to the suboptimal provision of palliative care. However, there is currently lacking a reliable and valid instrument for evaluating the self-efficacy of palliative care practitioners in China. Therefore, this study aimed to translate, adapt, and validate the Palliative Care Self-Efficacy Scale (PCSS) among Chinese palliative care professionals.

Source: uow.edu.au
Catalight Unveils Wellbeing Scale to Assess and Enhance the - Vimarsana News

Catalight Unveils Wellbeing Scale to Assess and Enhance the

Proven Accurate by Data Analysis in Recent Study, Scale Will Be Made Available to Outside Agencies...

"Measuring gerontological nursing competencies among aged care nurses: " by Mu Hsing Ho, Jung Jae Lee et al. - Vimarsana News

"Measuring gerontological nursing competencies among aged care nurses: " by Mu Hsing Ho, Jung Jae Lee et al.

Background: Existing gerontological nursing competencies include the requisite knowledge and skills required for aged care nursing. What were not previously considered were legal and ethical aspects and access to technology, e-health and social media. Objectives: This study aimed to validate an Australian gerontological nursing competencies scale and assess the factors associated with for aged care nurses in Taiwan. Methods: A methodological study design was used to validate the scale with a sample of 369 aged care nurses from aged care settings including nursing homes, long-term care faciliti...

Source: uow.edu.au
FDA Approves VYVANSE(TM) (lisdexamfetamine Dimesylate), The First And Only Once-Daily Prodrug Stimulant To Treat ADHD In Adults - Vimarsana News

FDA Approves VYVANSE(TM) (lisdexamfetamine Dimesylate), The First And Only Once-Daily Prodrug Stimulant To Treat ADHD In Adults

BASINGSTOKE, England and PHILADELPHIA, April 23 /PRNewswire/ -- - Within the First Eight Months Since its Introduction in the United States, VYVANSE has Achieved Over One Million Prescriptions - In a Clinical Study With Adults, VYVANSE was Shown to Significantly Improve the Symptoms of ADHD (Inattention, Hyperactivity and Impulsivity)(1)

MoCA tool to detect major neurocognitive disorder: Ethiopia. - Vimarsana News

MoCA tool to detect major neurocognitive disorder: Ethiopia.

To assess the reliability and validity of the Montreal Cognitive Assessment (MoCA) tool to detect major neurocognitive disorder among older people in Ethiopia.